Volume 8, Issue 1 (5-1994)                   Med J Islam Repub Iran 1994 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
AZARM T. AUTOLOGOUS MARROW TRANSPLANTATION IN THE TREATMENT OF MOPP AND ABVD-RESI STANT HODGKIN'S DISEASE. Med J Islam Repub Iran 1994; 8 (1) :9-16
URL: http://mjiri.iums.ac.ir/article-1-1397-en.html
AUTOLOGOUS MARROW TRANSPLANTATION IN THE TREATMENT OF MOPP AND ABVD-RESI STANT HODGKIN'S DISEASE
TALEB AZARM
From the Division of Hematology/Oncology and B.M.T., Seyyed-al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran.
Abstract:   (4075 Views)
Six patients with disseminated Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine and prednisolone), and ABVD (adriamycin, bleomycin, vinblastine and dacarbazine) chemotherapy were treated with high-dose chemotherapy and autologous marrow transplantation. The patients first underwent marrow aspiration and storage for subsequent autologous bone marrow transplantation (AB MT). Three patients remain alive in unmaintained complete remission (CR) at I X, 17, and 15 months after transplant. In the other three patients, reasons for faiJure included relapse in two patients after 7 and g months, and death after 6 months due to pulmonary infection (pneumonia). These results demonstrate that some patients with MOPP, ABVD and other salvage chemotherapy (SC)-resistant Hodgkin's disease can obtain prolonged complete remission following intensive chemotherapy and autologous marrow transplantation
Keywords: Autologous marrow transplantation, Hodgkin\'s disease.
Full-Text [PDF 787 kb]   (1596 Downloads)    
Type of Study: Original Research | Subject: Oncology
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.